JCM
ELV icon

JS Capital Management’s Elevance Health ELV Stock Holding History

JS Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-62,500
Closed -$7.48M – 61
2014
Q3 		$7.48M Sell
62,500
-2,500
-4% -$287K 1.21% 8
2014
Q2 		$7M Hold
65,000
– – 1.24% 12
2014
Q1 		$6.47M Sell
65,000
-65,000
-50% -$5.88M 0.98% 13
2013
Q4 		$12M Buy
+130,000
New +$11.6M 1.67% 8

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JS Capital Management's ELV Position: Q3 2023 in Review

JS Capital Management sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 13,000 shares — an estimated $5.78M sold.

JS Capital Management first reported a position in ELV in Q2 2017 and held it in 4 quarters. The position peaked at $6.21M in Q2 2017. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • JS Capital Management reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
  • JS Capital Management sold 13,000 Elevance Health shares in Q3 2023, an estimated $5.78M.
  • JS Capital Management first reported a position in Elevance Health in Q2 2017 and held it in 4 quarters.
  • JS Capital Management's Elevance Health position peaked at $6.21M in Q2 2017.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on JS Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.